# 21 U.S.C. 393a Office of Pediatric Therapeutics

21 U.S.C. 393a Office of Pediatric Therapeutics, “Office of Pediatric Therapeutics”, is a U.S. Code section of [Subchapter X—Miscellaneous](https://ontology.bommaritollc.com/id/01a0f06c-cbb4-77a7-9881-dfafb1e8cece); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f06c-cb65-7672-8fda-c39517ff08c0) › [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23) › [Subchapter X—Miscellaneous](https://ontology.bommaritollc.com/id/01a0f06c-cbb4-77a7-9881-dfafb1e8cece)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [usc-section 21 U.S.C. 393a](https://ontology.bommaritollc.com/id/01a0f06c-ce2c-77ea-ace5-d81bae1ea836)
- `eli:cites`:
  - [21 U.S.C. 355a Pediatric studies of drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd9-779c-b02d-f70feff4a7a0)
  - [21 U.S.C. 355c Research into pediatric uses for drugs and biological products](https://ontology.bommaritollc.com/id/01a0f06c-ccdc-7622-b131-6752c5c696e4)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapX-sec393a](https://ontology.bommaritollc.com/id/01a0f06c-ce2a-7024-882c-9be27e4e5f8b)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f06c-d18e-74f1-a205-7e1ab15e9e90)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d2-2e05-75c3-bb92-9e2abe1bfd7e)
  - [evidence from https://www.govinfo.gov/link/uscode/21/393a?type=usc&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f15-fe6a-72d1-ad2f-aae0991d41f6)
- `schema:isPartOf`: [Subchapter X—Miscellaneous](https://ontology.bommaritollc.com/id/01a0f06c-cbb4-77a7-9881-dfafb1e8cece)
- `schema:legislationIdentifier`: 21 U.S.C. 393a
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [U.S. Code section](https://ontology.bommaritollc.com/vocab/leg/uscSection)
- `schema:name`: Office of Pediatric Therapeutics
- `schema:url`: [https://www.govinfo.gov/link/uscode/21/393a?type=usc&year=mostrecent&link-type=details](https://www.govinfo.gov/link/uscode/21/393a?type=usc&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 U.S.C. 393a Office of Pediatric Therapeutics

## Elsewhere

- [Official page](https://www.govinfo.gov/link/uscode/21/393a?type=usc&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapX-sec393a) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Amended by (3; `eli:amends`):
  - [Pub. L. 110-85](https://ontology.bommaritollc.com/id/01a0f06c-d2ac-7439-ab06-bdf3d920772b)
  - [Pub. L. 112-144](https://ontology.bommaritollc.com/id/01a0f06a-a3b6-70e5-8204-79bb2755f506)
  - [Pub. L. 115-52](https://ontology.bommaritollc.com/id/01a0f06c-d2f5-7295-8628-c43a73a54615)
- Cited by (3; `eli:cites`):
  - [21 U.S.C. 355a Pediatric studies of drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd9-779c-b02d-f70feff4a7a0)
  - [21 U.S.C. 355b Adverse-event reporting](https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6)
  - [21 U.S.C. 360j General provisions respecting control of devices intended for human use](https://ontology.bommaritollc.com/id/01a0f06c-cd14-70a5-a599-4fff974986bc)
- Bodies it establishes (1; `bcorg:establishedBy`):
  - [Office of Pediatric Therapeutics](https://ontology.bommaritollc.com/id/01a0f0cc-2faf-7660-bfb9-36c0361ef947)
- Its changes, from (1; `eli:changes`):
  - [Pub. L. 107-109](https://ontology.bommaritollc.com/id/01a0f06c-d2a6-749e-9a14-41abc3b35120)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17)
Cite as: 21 U.S.C. 393a Office of Pediatric Therapeutics. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
